References
- Yeo TK, Ho SL, Lim WK, Teoh SC. Causes of visual loss associated with uveitis in a singapore tertiary eye center. Ocul Immunol Inflamm. 2013;21(4):264–269. doi:https://doi.org/10.3109/09273948.2013.774424.
- Sng CC, Barton K. Mechanism and management of angle closure in uveitis. Curr Opin Ophthalmol. 2015;26(2):121–127. doi:https://doi.org/10.1097/ICU.0000000000000136.
- Sng CC, Ang M, Barton K. Uveitis and glaucoma: new insights in the pathogenesis and treatment. Prog Brain Res. 2015;221:243–269.
- Munoz-Negrete FJ, Moreno-Montanes J, Hernandez-Martinez P, Rebolleda G. Current approach in the diagnosis and management of uveitic glaucoma. Biomed Res Int. 2015;2015:742792. doi:https://doi.org/10.1155/2015/742792.
- Sallam A, Sheth HG, Habot-Wilner Z, Lightman S. Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response. Am J Ophthalmol. 2009;148(2):207–213e201. doi:https://doi.org/10.1016/j.ajo.2009.02.032.
- Siddique SS, Suelves AM, Baheti U, Foster CS. Glaucoma and uveitis. Surv Ophthalmol. 2013;58(1):1–10. doi:https://doi.org/10.1016/j.survophthal.2012.04.006.
- Iverson SM, Bhardwaj N, Shi W, et al. Surgical outcomes of inflammatory glaucoma: a comparison of trabeculectomy and glaucoma-drainage-device implantation. Jpn J Ophthalmol. 2015;59(3):179–186. doi:https://doi.org/10.1007/s10384-015-0372-6.
- Noble J, Derzko-Dzulynsky L, Rabinovitch T, Birt C. Outcome of trabeculectomy with intraoperative mitomycin C for uveitic glaucoma. Can J Ophthalmol J Can D’ophtalmologie. 2007;42:89–94.
- Kalinina Ayuso V, Scheerlinck LM, de Boer JH. The effect of an Ahmed glaucoma valve implant on corneal endothelial cell density in children with glaucoma secondary to uveitis. Am J Ophthalmol. 2013;155(3):530–535. doi:https://doi.org/10.1016/j.ajo.2012.09.001.
- Iordanous Y, Kent JS, Hutnik CM, Malvankar-Mehta MS. Projected cost comparison of trabectome, iStent, and endoscopic cyclophotocoagulation versus glaucoma medication in the ontario health insurance plan. J Glaucoma. 2014;23(2):e112–118. doi:https://doi.org/10.1097/IJG.0b013e31829d9bc7.
- Sayed MS, Lee RK. Current management approaches for uveitic glaucoma. Int Ophthalmol Clin. 2015;55(3):141–160. doi:https://doi.org/10.1097/IIO.0000000000000071.
- Leahy KE, White AJ. Selective laser trabeculoplasty: current perspectives. Clin Ophthalmol. 2015;9:833–841. doi:https://doi.org/10.2147/OPTH.S53490.
- Gupta V, Ghosh S, Sujeeth M, et al. Selective laser trabeculoplasty for primary open-angle glaucoma patients younger than 40 years. Can J Ophthalmol J Can D’ophtalmologie. 2018;53(1):81–85. doi:https://doi.org/10.1016/j.jcjo.2017.07.023.
- Samples JR, Singh K, Lin SC, et al. Laser trabeculoplasty for open-angle glaucoma: a report by the american academy of ophthalmology. Ophthalmology. 2011;118(11):2296–2302. doi:https://doi.org/10.1016/j.ophtha.2011.04.037.
- Koucheki B, Hashemi H. Selective laser trabeculoplasty in the treatment of open-angle glaucoma. J Glaucoma. 2012;21(1):65–70. doi:https://doi.org/10.1097/IJG.0b013e3182027596.
- Koktekir BE, Gedik S, Bakbak B. Bilateral severe anterior uveitis after unilateral selective laser trabeculoplasty. Clin Exp Ophthalmol. 2013;41:305–307.
- Maleki A, Swan RT, Lasave AF, Ma L, Foster CS. Selective laser trabeculoplasty in controlled uveitis with steroid-induced glaucoma. Ophthalmology. 2016;123(12):2630–2632. doi:https://doi.org/10.1016/j.ophtha.2016.07.027.
- Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. results of the first international workshop. Am J Ophthalmol. 2005;140:509–516.
- Kaburaki T, Namba K, Sonoda KH, et al. Behcet’s disease ocular attack score 24: evaluation of ocular disease activity before and after initiation of infliximab. Jpn J Ophthalmol. 2014;58(2):120–130. doi:https://doi.org/10.1007/s10384-013-0294-0.
- Alvarado JA, Katz LJ, Trivedi S, Shifera AS. Monocyte modulation of aqueous outflow and recruitment to the trabecular meshwork following selective laser trabeculoplasty. Arch Ophthalmol. 2010;128(6):731–737. doi:https://doi.org/10.1001/archophthalmol.2010.85.
- Alvarado JA, Betanzos A, Franse-Carman L, Chen J, Gonzalez-Mariscal L. Endothelia of Schlemm’s canal and trabecular meshwork: distinct molecular, functional, and anatomic features. Am J Physiol Cell Physiol. 2004;286(3):C621–634. doi:https://doi.org/10.1152/ajpcell.00108.2003.
- Kinori M, Hostovsky A, Skaat A, Schwartsman J, Melamed S. A novel method for quantifying the amount of trabecular meshwork pigment in glaucomatous and nonglaucomatous eyes. J Glaucoma. 2014;23(1):e13–17. doi:https://doi.org/10.1097/IJG.0b013e3182a0758c.
- Lee JW, Wong MO, Liu CC, Lai JS. Optimal selective laser trabeculoplasty energy for maximal intraocular pressure reduction in open-angle glaucoma. J Glaucoma. 2015;24(5):e128–131. doi:https://doi.org/10.1097/IJG.0000000000000215.
- Habib L, Lin J, Berezina T, Holland B, Fechtner RD, Khouri AS. Selective laser trabeculoplasty: does energy dosage predict response? Oman J Ophthalmol. 2013;6(2):92–95. doi:https://doi.org/10.4103/0974-620X.116635.
- Kimura SJ. Fuchs’ syndrome of heterochromic cyclitis in brown-eyed patients. Trans Am Ophthalmol Soc. 1978;76:76–89.
- Qing G, Wang N, Lu Q, Zhang S. Different transillumination property in Chinese and white irides. J Glaucoma. 2012;21(2):107–111. doi:https://doi.org/10.1097/IJG.0b013e318202794d.
- Garg A, Gazzard G. Selective laser trabeculoplasty: past, present, and future. Eye (Lond). 2018;32(5):863–876. doi:https://doi.org/10.1038/eye.2017.273.
- De Keyser M, De Belder M, De Groot V. Randomized prospective study of the use of anti-inflammatory drops after selective laser trabeculoplasty. J Glaucoma. 2017;26(2):e22–e29. doi:https://doi.org/10.1097/IJG.0000000000000522.
- Jinapriya D, D’Souza M, Hollands H, et al. Anti-inflammatory therapy after selective laser trabeculoplasty: a randomized, double-masked, placebo-controlled clinical trial. Ophthalmology. 2014;121(12):2356–2361. doi:https://doi.org/10.1016/j.ophtha.2014.07.017.